Literature DB >> 4714096

Levodopa therapy for Parkinsonism in the Shy-Drager syndrome.

M J Aminoff, C S Wilcox, M M Woakes, M Kremer.   

Abstract

The results of levodopa treatment in five patients with Parkinsonism of the Shy-Drager syndrome are reported. There was no improvement in the neurological signs or functional disability in any patient. Mean values for lying and standing blood pressure increased significantly in three of the five patients during treatment, and were unchanged in the other two patients. The significance of these results is discussed. It is concluded that levodopa is not of therapeutic value in patients with this disorder.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4714096      PMCID: PMC494332          DOI: 10.1136/jnnp.36.3.350

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  24 in total

1.  Modification of Parkinsonism--chronic treatment with L-dopa.

Authors:  G C Cotzias; P S Papavasiliou; R Gellene
Journal:  N Engl J Med       Date:  1969-02-13       Impact factor: 91.245

2.  Effects of L-dopa in Parkinson's disease.

Authors:  R B Godwin-Austen; E B Tomlinson; C C Frears; H W Kok
Journal:  Lancet       Date:  1969-07-26       Impact factor: 79.321

3.  L-dopa in postencephalitic parkinsonism.

Authors:  D B Calne; G M Stern; D R Laurence; J Sharkey; P Armitage
Journal:  Lancet       Date:  1969-04-12       Impact factor: 79.321

4.  Autonomic failure with orthostatic hypotension due to intermediolateral column degeneration. A report of two cases with autopsies.

Authors:  R H Johnson; G de J Lee; D R Oppenheimer; J M Spalding
Journal:  Q J Med       Date:  1966-04

5.  [Idiopathic orthostatic hypotension with a complex neurological syndrome of extrapyramidal predominance].

Authors:  J Nick; F Contamin; R Escourolle; A Guillard; J P Marcantoni
Journal:  Rev Neurol (Paris)       Date:  1967-03       Impact factor: 2.607

6.  The orthostatic hypotension syndrome of Shy-Drager. A clinicopathologic report.

Authors:  G A Schwarz
Journal:  Arch Neurol       Date:  1967-02

Review 7.  Dopamine (3-hydroxytyramine) and brain function.

Authors:  O Hornykiewicz
Journal:  Pharmacol Rev       Date:  1966-06       Impact factor: 25.468

8.  L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism.

Authors:  M D Yahr; R C Duvoisin; M M Hoehn; M J Schear; R E Barrett
Journal:  Trans Am Neurol Assoc       Date:  1968

9.  The action of dopamine on neurones of the caudate nucleus.

Authors:  H McLennan; D H York
Journal:  J Physiol       Date:  1967-04       Impact factor: 5.182

10.  Micro-iontophoretic studies on neurones in the cuneate nucleus.

Authors:  A Galindo; K Krnjević; S Schwartz
Journal:  J Physiol       Date:  1967-09       Impact factor: 5.182

View more
  4 in total

1.  The use of lisuride in the treatment of multiple system atrophy with autonomic failure (Shy-Drager syndrome).

Authors:  A J Lees; R Bannister
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-04       Impact factor: 10.154

2.  Blood pressure responses to noradrenaline and dopamine infusions in Parkinson's disease and the Shy-Drager syndrome.

Authors:  C S Wilcox; M J Aminoff
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

3.  Basis of nocturnal polyuria in patients with autonomic failure.

Authors:  C S Wilcox; M J Aminoff; W Penn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-06       Impact factor: 10.154

4.  Tremor in Multiple System Atrophy - a review.

Authors:  Christine Kaindlstorfer; Roberta Granata; Gregor Karl Wenning
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2013-09-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.